Sutro Biopharma Inc
Sutro Biopharma Inc (STRO) Straddle
STRO straddle scan found 12 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 63.4%.
Read more
Trading a STRO straddle lets you take a pure volatility position on Sutro Biopharma Inc without committing to a direction. Sutro Biopharma Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate STRO straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on STRO profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Sutro Biopharma Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the STRO straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials.
It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the STRO straddle is the cleanest expression of that view. Our scanner prices every STRO straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a STRO straddle into a catalyst or short a STRO straddle to harvest decay, the options straddle setups that matter are all in one place.
| Feb 19, 2027 | 25.00 | $12.25 | 158 | 38% | 63.4% | $37.25 | $12.75 | 0 |
| Feb 19, 2027 | 22.50 | $10.50 | 158 | 38% | 63.1% | $33.00 | $12.00 | 0 |
| Feb 19, 2027 | 30.00 | $16.75 | 158 | 38% | 61.5% | $46.75 | $13.25 | 0 |
| Feb 19, 2027 | 20.00 | $9.83 | 158 | 38% | 58.1% | $29.83 | $10.18 | 0 |
| Nov 20, 2026 | 20.00 | $7.30 | 67 | 38% | 54.4% | $27.30 | $12.70 | 4 |
| Feb 19, 2027 | 17.50 | $8.85 | 158 | 38% | 54.4% | $26.35 | $8.65 | 0 |
| Nov 20, 2026 | 17.50 | $6.10 | 67 | 38% | 53.6% | $23.60 | $11.40 | 0 |
| Nov 20, 2026 | 22.50 | $9.25 | 67 | 38% | 52.5% | $31.75 | $13.25 | 0 |
| Feb 19, 2027 | 15.00 | $8.38 | 158 | 38% | 47.5% | $23.38 | $6.63 | 1 |
| Oct 16, 2026 | 22.50 | $7.93 | 32 | 38% | 47.4% | $30.43 | $14.58 | 0 |
As of September 16, 2026
Find the right straddle before volatility moves
Track STRO straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→